Abstract
Non-inflammatory cystic lesions of the pancreas are increasingly recognized. Two distinct entities have been defined, i.e., intraductal papillary mucinous neoplasm (IPMN) and mucinous cystic neoplasm (MCN). Ovarian-type stroma has been proposed as a requisite to distinguish MCN from IPMN. Some other distinct features to characterize IPMN and MCN have been identified, but there remain ambiguities between the two diseases. In view of the increasing frequency with which these neoplasms are being diagnosed worldwide, it would be helpful for physicians managing patients with cystic neoplasms of the pancreas to have guidelines for the diagnosis and treatment of IPMN and MCN. The proposed guidelines represent a consensus of the working group of the International Association of Pancreatology.
Original language | English (US) |
---|---|
Pages (from-to) | 17-32 |
Number of pages | 16 |
Journal | Pancreatology |
Volume | 6 |
Issue number | 1-2 |
DOIs | |
State | Published - Apr 2006 |
Keywords
- Guidelines for management of IPMN/MCN
- Intraductal papillary mucinous neoplasm
- Mucinous cystic neoplasm
- Pancreatectomy
- Pancreatic neoplasm
ASJC Scopus subject areas
- Endocrinology
- Endocrinology, Diabetes and Metabolism
- Hepatology